| Fred Peyerl, PhD |
Fig. 01 -
Title
Fig. 02 -
Overview
Fig. 03 -
Barnes-NIV-COPD
Fig. 04 -
Barnes - High Risk Patients
Fig. 05 -
AVAPS-AE is an auto-titration mode
Fig. 06 -
Range of Services
Fig. 07 -
Criteria to Qualify
Fig. 08 -
Economic Impact
Fig. 09 -
BIM 5-Year Coverage
Fig. 10 -
Factors by Stakeholders
Fig. 11 -
Model Outcomes
Fig. 12 -
Comprehensive Model Parameters
Fig. 13 -
Summarized Costs/Savings
Fig. 14 -
Hospitalized Patient Outcomes
Fig. 15 -
Hospital Model Analysis
Fig. 16 -
DME Provider Patient Outcomes
Fig. 17 -
DME Provider Model Analysis
Fig. 18 -
Payer Patient Outcomes
Fig. 19 -
Payer Model Analysis
Fig. 20 -
Cumulative 5 year savings
Fig. 21 -
Similarities in 5-year Savings
Fig. 22 -
Overall Summary
Fig. 23 -
Faculty Roundtable Discussion
TODO, let Pete know of any updates to this content
Six (6) provocative statements concerning clinical treatment of IBD. Each statement is presented as 5 steps:Step 1: the statement & introduction, + 5 possible opinions of that statement -- please choose one
Step 2: a graph of an international survey’s opinions of that statement
Step 3: a literature review for that statement
Step 4: a graph comparing the faculty's vs an international survey’s opinions, + faculty discussion
Step 5: a brief faculty summary, plus the list of references.
Please click on any Statement or any Step tab to read this publication in the order you prefer.
